Skip to main content
. 2014 Jan;12(1):40–49. doi: 10.2450/2013.0088-13

Figure 2.

Figure 2

Allogeneic red cell transfusion (ARCT) rate (%) and blood management costs in two series of patients undergoing lower limb arthroplasty, managed with (PIVI group) or without (control group) post-operative intravenous iron administration, according to pre-operative haemoglobin level (preOP Hb) (A) and three possible cost scenarios (ALO-1, ALO-2, ALO) (B and C) (see Methods section for further details).

*p<0.05, PIVI group vs control group.